Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
FLAG-Ida for acute myeloid leukaemia (AML). A guide for patients

FLAG-Ida for acute myeloid leukaemia (AML). A guide for patients (January 2020)

FLAG-Ida is a combination chemotherapy regimen used in the treatment of acute myeloid leukaemia (AML). It consists of fludarabine, high dose cytarabine (Ara-C0), idarubicin and granulocyte-colony stimulating factor (G-CSF). This booklet explains the drugs, who may be eligible to receive this treatment, how FLAG-Ida is given, and the possible side-effects. Includes a glossary and details of further support and information.

Author(s)
Leukaemia Care
Place of publication
Worcester
Publisher
Date of publication
January 2020
Pages
20pp
Format
Booklet
Language
English
Flesch readability score
41.9
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm